IBDEI0SR ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13486,1,3,0)
 ;;=3^Malig Neop Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,13486,1,4,0)
 ;;=4^C34.90
 ;;^UTILITY(U,$J,358.3,13486,2)
 ;;=^5000966
 ;;^UTILITY(U,$J,358.3,13487,0)
 ;;=C65.9^^53^593^150
 ;;^UTILITY(U,$J,358.3,13487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13487,1,3,0)
 ;;=3^Malig Neop Renal Pelvis,Unspec
 ;;^UTILITY(U,$J,358.3,13487,1,4,0)
 ;;=4^C65.9
 ;;^UTILITY(U,$J,358.3,13487,2)
 ;;=^5001253
 ;;^UTILITY(U,$J,358.3,13488,0)
 ;;=C50.912^^53^593^131
 ;;^UTILITY(U,$J,358.3,13488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13488,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,13488,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,13488,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,13489,0)
 ;;=C50.911^^53^593^153
 ;;^UTILITY(U,$J,358.3,13489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13489,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,13489,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,13489,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,13490,0)
 ;;=C50.919^^53^593^123
 ;;^UTILITY(U,$J,358.3,13490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13490,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,13490,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,13490,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,13491,0)
 ;;=C62.90^^53^593^161
 ;;^UTILITY(U,$J,358.3,13491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13491,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,13491,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,13491,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,13492,0)
 ;;=D03.9^^53^593^165
 ;;^UTILITY(U,$J,358.3,13492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13492,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,13492,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,13492,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,13493,0)
 ;;=C45.0^^53^593^166
 ;;^UTILITY(U,$J,358.3,13493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13493,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,13493,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,13493,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,13494,0)
 ;;=C90.01^^53^593^168
 ;;^UTILITY(U,$J,358.3,13494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13494,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,13494,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,13494,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,13495,0)
 ;;=C90.00^^53^593^169
 ;;^UTILITY(U,$J,358.3,13495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13495,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,13495,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,13495,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,13496,0)
 ;;=C94.6^^53^593^170
 ;;^UTILITY(U,$J,358.3,13496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13496,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,13496,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,13496,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,13497,0)
 ;;=D61.82^^53^593^171
 ;;^UTILITY(U,$J,358.3,13497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13497,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,13497,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,13497,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,13498,0)
 ;;=D47.9^^53^593^172
 ;;^UTILITY(U,$J,358.3,13498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13498,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,13498,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,13498,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,13499,0)
 ;;=D53.9^^53^593^176
 ;;^UTILITY(U,$J,358.3,13499,1,0)
 ;;=^358.31IA^4^2
